Durability of Early Initial Combination Therapy With Exenatide/Pioglitazone/Metformin vs Conventional Therapy in New Onset Type 2 Diabetes
Phase of Trial: Phase III
Latest Information Update: 17 Aug 2017
At a glance
- Drugs Exenatide (Primary) ; Metformin (Primary) ; Pioglitazone (Primary) ; Glibenclamide; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 11 Aug 2017 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 11 Aug 2017 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2020.
- 14 Jul 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History